ABT 724 trihydrochloride
Cat. No. 2214
Chemical Name: 2-[[4-(2-Pyridinyl)-1-piperazinyl]m
Biological ActivityPotent dopamine D4 receptor partial agonist (EC50 = 12.4 nM; 61% efficacy vs. dopamine). Has no agonist activity at D2 receptors (EC50 > 10 μM). Selective in rats in vivo; produces penile erection following i.c.v. administration; increases intracavernosal pressure and potentiates the proerectile effects of sildenafil following s.c. administration. Displays minimal side effects.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Brioni et al (2004) Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats. Proc.Natl.Acad.Sci.USA 101 6758.
Cowart et al (2004) Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction. J.Med.Chem. 47 3853. PMID: 15239663.
Stewart et al (2004) Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning. J.Med.Chem. 47 2348. PMID: 15084133.
If you know of a relevant reference for ABT 724 trihydrochloride please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses ABT 724 trihydrochloride from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: ABT 724 trihydrochloride, supplier, Potent, selective, D4, partial, agonists, proerectile, Dopamine, Receptors, dopaminergic, ABT724, trihydrochloride, Tocris Bioscience, D4 Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
G protein-biased D2 receptor partial agonist
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.